20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T14002 | 12-Ketodeoxycholic acid | Endogenous Metabolite | |
12-Ketodeoxycholic acid, a bile acid and kidney metabolite, serves as a detectable marker for kidney injury [1]. | |||
T7802 | M1001 | HIF/HIF Prolyl-Hydroxylase , HIF | |
M1001 is a HIF-2α agonist. | |||
T9022 | AZD9977 | AZD 9977 | Glucocorticoid Receptor |
AZD9977 is a novel, selective modulator of mineralocorticoid receptor . | |||
T4583 | PFI-2 hydrochloride | (R)-PFI-2 hydrochloride,PFI-2 HCl | Histone Methyltransferase |
PFI-2 hydrochloride ((R)-PFI-2 hydrochloride) is a potent, highly selective, and cell-active inhibitor of the methyltransferase activity of SETD7 (IC50: 2 nM), 500 fold active than (S)-PFI-2. | |||
T21395 | Finerenone | BAY948862,BAY-948862,BAY94-8862,BAY 94-8862,BAY-94-8862,BAY 948862 | Glucocorticoid Receptor |
Finerenone (BAY-948862) is a third-generation, selective, and orally available nonsteroidal mineralocorticoid receptor (MR) antagonist with IC50 of 18 nM for the treatment of chronic heart failure. Finerenone (BAY-948862... | |||
T6666 | Sevelamer Carbonate | Others | |
Sevelamer carbonate is a non-absorbed phosphate binding crosslinked polymer, with the same polymeric structure as sevelamer hydrochloride, in which carbonate replaces chloride as the counterion. | |||
T1987 | PFI-2 | PFI2,PFI 2,(R)-PFI-2 | Histone Methyltransferase |
PFI-2 is an effective, specific and cell-active lysine methyltransferase SETD7 inhibitor (Ki/IC50: 0.33/2 nM), 1000-fold selectivity over other methyltransferases and other non-epigenetic targets. | |||
T13591 | Calcium polystyrene sulfonate | Poly(styrenesulfonic acid) calcium salt | Others |
Calcium polystyrene sulfonate (Poly(styrenesulfonic acid) calcium salt) is an ion-exchange resin. Calcium polystyrene sulfonate reduces blood levels of potassium and can be used for research on the treatment of hyperkale... | |||
T21977 | P-Cresyl sulfate | Others | |
p-Cresyl Sulfate is a major uremic toxin found in the blood of patients with chronic kidney disease (CKD), derived from the metabolites of tyrosine and phenylalanine in the liver. | |||
T30479 | Bis-T-23 | Bis T-23,Bis-T 23,AG1717 | HIV Protease |
Bis-T-23 is a promoter of actin-dependent dynamin oligomerization, an HIV-I integrase inhibitor, and a Telstar derivative. Bis-T-23 promotes actin-dependent dynamin oligomerization. Bis-T-23 can be used in studies of HIV... | |||
T13604 | CDDO-dhTFEA | Others , NF-κB , Nrf2 | |
CDDO-dhTFEA, a synthetic oleanane triterpenoid, effectively activates Nrf2 while inhibiting the NF-κB pro-inflammatory transcription factor. It restores mean arterial pressure (MAP), elevates Nrf2 levels and the expressi... | |||
T4938 | Potassium 1H-indol-3-yl sulfate | Indoxyl sulfate potassium salt,Potassium 3-indoxyl sulfate | AhR , Endogenous Metabolite |
Potassium 1H-indol-3-yl sulfate (Potassium 3-indoxyl sulfate) is an agonist for the human Aryl Hydrocarbon Receptor (AhR). The Aryl Hydrocarbon Receptor (AhR) has recently emerged as a pathophysiological regulator of imm... | |||
T28222 | 5-Hydroxy-1-methylhydantoin | HD-003,HD003,NZ419,NZ-419,HD 003,NZ 419 | Bradykinin Receptor |
5-Hydroxy-1-methylhydantoin (HD-003) is an antioxidant potentially for the treatment of renal failure. A creatinine metabolite, 5-Hydroxy-1-methylhydantoin , a hydroxyl radical scavenger, has previously been shown to con... | |||
T32193 | Iron sorbitex | Jectofer,Yectofer,Iron Sorbitol,HSDB 1967,Astra 1572 | |
Iron Sorbitex is used for the treatment of Iron Sorbitex deficiency anemia in patients with chronic kidney disease. Iron Sorbitex can be used as an Iron Sorbitex replacement product used for the treatment of Iron Sorbite... | |||
T39410 | Zevaquenabant | (S)-MRI-1867 | |
Zevaquenabant ((S)-MRI-1867), a dual cannabinoid CB1 receptor and inducible NOS (iNOS) antagonist, is orally bioavailable and peripherally restricted. It effectively mitigates obesity-induced chronic kidney disease (CKD)... | |||
T38419 | Difelikefalin | CR-845,FE-202845 | |
Difelikefalin (CR-845; FE-202845) is a peripherally restricted, selective agonist of the kappa opioid receptor (KOR). It exhibits anti-inflammatory properties and holds promise for modulating pruritus in conditions assoc... | |||
T60937 | TRPC5-IN-1 | ||
TRPC5-IN-1 is a TRPC5 inhibitor active in various animal models of chronic kidney disease. | |||
T73332 | BI-685509 | ||
BI-685509 is a potent and orally active sGC activator. BI-685509 restores cyclic guanosine monophosphate (cGMP) and improves functionality of nitric oxide (NO) pathways. BI-685509 can be used in research of chronic kidne... | |||
T69294 | UK‑396082 | ||
UK-396082 is a potent inhibitor of thrombin-activated fibrinolytic inhibitor (TAFI), enhancing plasmin activity while concurrently reducing levels of the extracellular matrix (ECM). This compound is valuable for research... | |||
T80220 | OK2 | EGFR | |
OK2, a specific inhibitor of the CCN2/EGFR interaction, effectively disrupts this interaction by binding to the CT domain of CCN2. It holds potential for use in research pertaining to kidney fibrosis and chronic kidney d... |